AVANOS MEDICAL INC (AVNS) Fundamental Analysis & Valuation

NYSE:AVNS • US05350V1061

Current stock price

13.52 USD
-0.33 (-2.38%)
At close:
13.52 USD
0 (0%)
After Hours:

This AVNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. AVNS Profitability Analysis

1.1 Basic Checks

  • AVNS had positive earnings in the past year.
  • In the past year AVNS had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AVNS reported negative net income in multiple years.
  • In the past 5 years AVNS always reported a positive cash flow from operatings.
AVNS Yearly Net Income VS EBIT VS OCF VS FCFAVNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • AVNS has a better Return On Assets (-6.79%) than 67.20% of its industry peers.
  • AVNS has a Return On Equity of -9.37%. This is in the better half of the industry: AVNS outperforms 68.78% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.47%, AVNS is in the better half of the industry, outperforming 68.25% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AVNS is significantly below the industry average of 9.31%.
Industry RankSector Rank
ROA -6.79%
ROE -9.37%
ROIC 1.47%
ROA(3y)-14.8%
ROA(5y)-8.25%
ROE(3y)-20.56%
ROE(5y)-11.47%
ROIC(3y)1.82%
ROIC(5y)2.02%
AVNS Yearly ROA, ROE, ROICAVNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • AVNS has a Operating Margin of 2.41%. This is in the better half of the industry: AVNS outperforms 68.25% of its industry peers.
  • AVNS's Operating Margin has declined in the last couple of years.
  • The Gross Margin of AVNS (50.47%) is comparable to the rest of the industry.
  • AVNS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.41%
PM (TTM) N/A
GM 50.47%
OM growth 3Y-36.17%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-0.68%
AVNS Yearly Profit, Operating, Gross MarginsAVNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. AVNS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVNS is destroying value.
  • Compared to 1 year ago, AVNS has more shares outstanding
  • Compared to 5 years ago, AVNS has less shares outstanding
  • Compared to 1 year ago, AVNS has an improved debt to assets ratio.
AVNS Yearly Shares OutstandingAVNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AVNS Yearly Total Debt VS Total AssetsAVNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • AVNS has an Altman-Z score of 1.21. This is a bad value and indicates that AVNS is not financially healthy and even has some risk of bankruptcy.
  • AVNS has a Altman-Z score (1.21) which is in line with its industry peers.
  • AVNS has a debt to FCF ratio of 2.33. This is a good value and a sign of high solvency as AVNS would need 2.33 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 2.33, AVNS belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • A Debt/Equity ratio of 0.12 indicates that AVNS is not too dependend on debt financing.
  • AVNS has a better Debt to Equity ratio (0.12) than 64.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 2.33
Altman-Z 1.21
ROIC/WACC0.14
WACC10.48%
AVNS Yearly LT Debt VS Equity VS FCFAVNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • AVNS has a Current Ratio of 2.15. This indicates that AVNS is financially healthy and has no problem in meeting its short term obligations.
  • AVNS has a Current ratio (2.15) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.26 indicates that AVNS should not have too much problems paying its short term obligations.
  • AVNS's Quick ratio of 1.26 is on the low side compared to the rest of the industry. AVNS is outperformed by 66.14% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.26
AVNS Yearly Current Assets VS Current LiabilitesAVNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AVNS Growth Analysis

3.1 Past

  • The earnings per share for AVNS have decreased strongly by -25.40% in the last year.
  • The Earnings Per Share has been growing slightly by 3.80% on average over the past years.
  • AVNS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.95%.
  • AVNS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.38% yearly.
EPS 1Y (TTM)-25.4%
EPS 3Y-17.1%
EPS 5Y3.8%
EPS Q2Q%-30.95%
Revenue 1Y (TTM)1.95%
Revenue growth 3Y-5.08%
Revenue growth 5Y-0.38%
Sales Q2Q%0.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.51% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.19% on average over the next years.
EPS Next Y8.62%
EPS Next 2Y16.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.16%
Revenue Next 2Y3.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AVNS Yearly Revenue VS EstimatesAVNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
AVNS Yearly EPS VS EstimatesAVNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. AVNS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.38 indicates a correct valuation of AVNS.
  • Based on the Price/Earnings ratio, AVNS is valued cheaply inside the industry as 87.83% of the companies are valued more expensively.
  • AVNS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.88.
  • AVNS is valuated correctly with a Price/Forward Earnings ratio of 13.24.
  • 89.42% of the companies in the same industry are more expensive than AVNS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, AVNS is valued a bit cheaper.
Industry RankSector Rank
PE 14.38
Fwd PE 13.24
AVNS Price Earnings VS Forward Price EarningsAVNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AVNS is valued cheaply inside the industry as 87.30% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, AVNS is valued cheaper than 95.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.59
EV/EBITDA 11.74
AVNS Per share dataAVNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as AVNS's earnings are expected to grow with 16.51% in the coming years.
PEG (NY)1.67
PEG (5Y)3.78
EPS Next 2Y16.51%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AVNS Dividend Analysis

5.1 Amount

  • No dividends for AVNS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVNS Fundamentals: All Metrics, Ratios and Statistics

AVANOS MEDICAL INC

NYSE:AVNS (3/27/2026, 8:04:00 PM)

After market: 13.52 0 (0%)

13.52

-0.33 (-2.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners97.21%
Inst Owner Change27.64%
Ins Owners2.94%
Ins Owner Change6.58%
Market Cap628.82M
Revenue(TTM)701.20M
Net Income(TTM)-72.90M
Analysts43.33
Price TargetN/A
Short Float %5.84%
Short Ratio4.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.19%
Min EPS beat(2)14.64%
Max EPS beat(2)79.74%
EPS beat(4)4
Avg EPS beat(4)36.78%
Min EPS beat(4)11.11%
Max EPS beat(4)79.74%
EPS beat(8)5
Avg EPS beat(8)16.95%
EPS beat(12)7
Avg EPS beat(12)15.54%
EPS beat(16)10
Avg EPS beat(16)13.47%
Revenue beat(2)2
Avg Revenue beat(2)3.74%
Min Revenue beat(2)1.52%
Max Revenue beat(2)5.97%
Revenue beat(4)4
Avg Revenue beat(4)3.17%
Min Revenue beat(4)1.52%
Max Revenue beat(4)5.97%
Revenue beat(8)4
Avg Revenue beat(8)0.74%
Revenue beat(12)4
Avg Revenue beat(12)-0.83%
Revenue beat(16)4
Avg Revenue beat(16)-4.39%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-39.13%
EPS NQ rev (3m)-39.13%
EPS NY rev (1m)5.37%
EPS NY rev (3m)5.37%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.38
Fwd PE 13.24
P/S 0.9
P/FCF 14.59
P/OCF 8.42
P/B 0.81
P/tB 2.37
EV/EBITDA 11.74
EPS(TTM)0.94
EY6.95%
EPS(NY)1.02
Fwd EY7.55%
FCF(TTM)0.93
FCFY6.85%
OCF(TTM)1.61
OCFY11.88%
SpS15.08
BVpS16.73
TBVpS5.71
PEG (NY)1.67
PEG (5Y)3.78
Graham Number18.81
Profitability
Industry RankSector Rank
ROA -6.79%
ROE -9.37%
ROCE 1.86%
ROIC 1.47%
ROICexc 1.63%
ROICexgc 4.36%
OM 2.41%
PM (TTM) N/A
GM 50.47%
FCFM 6.15%
ROA(3y)-14.8%
ROA(5y)-8.25%
ROE(3y)-20.56%
ROE(5y)-11.47%
ROIC(3y)1.82%
ROIC(5y)2.02%
ROICexc(3y)2.02%
ROICexc(5y)2.23%
ROICexgc(3y)5.81%
ROICexgc(5y)7.12%
ROCE(3y)2.3%
ROCE(5y)2.56%
ROICexgc growth 3Y-33.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y-26.31%
ROICexc growth 5YN/A
OM growth 3Y-36.17%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-0.68%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 2.33
Debt/EBITDA 1.62
Cap/Depr 81.23%
Cap/Sales 4.51%
Interest Coverage 2.6
Cash Conversion 133.87%
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.26
Altman-Z 1.21
F-Score6
WACC10.48%
ROIC/WACC0.14
Cap/Depr(3y)52.99%
Cap/Depr(5y)50.85%
Cap/Sales(3y)3.25%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.4%
EPS 3Y-17.1%
EPS 5Y3.8%
EPS Q2Q%-30.95%
EPS Next Y8.62%
EPS Next 2Y16.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.95%
Revenue growth 3Y-5.08%
Revenue growth 5Y-0.38%
Sales Q2Q%0.72%
Revenue Next Year2.16%
Revenue Next 2Y3.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-62.19%
EBIT growth 3Y-39.42%
EBIT growth 5YN/A
EBIT Next Year165.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.01%
FCF growth 3Y-15.57%
FCF growth 5YN/A
OCF growth 1Y-25.82%
OCF growth 3Y-6.33%
OCF growth 5YN/A

AVANOS MEDICAL INC / AVNS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AVANOS MEDICAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to AVNS.


What is the valuation status for AVNS stock?

ChartMill assigns a valuation rating of 6 / 10 to AVANOS MEDICAL INC (AVNS). This can be considered as Fairly Valued.


Can you provide the profitability details for AVANOS MEDICAL INC?

AVANOS MEDICAL INC (AVNS) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for AVNS stock?

The Earnings per Share (EPS) of AVANOS MEDICAL INC (AVNS) is expected to grow by 8.62% in the next year.